Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
C609595-1mg | 1mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $185.90 | |
C609595-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $415.90 | |
C609595-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $613.90 | |
C609595-25mg | 25mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $937.90 | |
C609595-50mg | 50mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $979.90 |
Synonyms | 6-imidazol-1-yl-2-phenylquinazoline | cr4056 | CR-4056 | 2-Phenyl-6-(1H-imidazol-1-yl)quinazoline | 6-(1H-imidazol-1-yl)-2-phenylquinazoline | Quinazoline |
---|---|
Specifications & Purity | Moligand™, ≥98% |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Inhibitor of Monoamine oxidase A |
Product Description |
CR4056 (6-(1H-imidazol-1-yl)-2-phenylquinazoline) is a selective inhibitor of MAO-A with IC50 of 202.7 nM and a ligand of I2-imidazoline receptor with IC50 of 596 nM.
|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | 6-imidazol-1-yl-2-phenylquinazoline |
---|---|
INCHI | InChI=1S/C17H12N4/c1-2-4-13(5-3-1)17-19-11-14-10-15(6-7-16(14)20-17)21-9-8-18-12-21/h1-12H |
InChi Key | CSZGXYBGYFNSCO-UHFFFAOYSA-N |
Canonical SMILES | C1=CC=C(C=C1)C2=NC=C3C=C(C=CC3=N2)N4C=CN=C4 |
Isomeric SMILES | C1=CC=C(C=C1)C2=NC=C3C=C(C=CC3=N2)N4C=CN=C4 |
Alternate CAS | 1004997-71-0 |
PubChem CID | 24898732 |
MeSH Entry Terms | CR4056 |
Molecular Weight | 272.3 |
PubChem CID | 24898732 |
---|---|
ChEMBL Ligand | CHEMBL2179398 |
BindingDB Ligand | 113058 |
CAS Registry No. | 1004997-71-0 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
G2418177 | Certificate of Analysis | Apr 17, 2024 | C609595 |
G2418178 | Certificate of Analysis | Apr 17, 2024 | C609595 |
G2418179 | Certificate of Analysis | Apr 17, 2024 | C609595 |
G2418181 | Certificate of Analysis | Apr 17, 2024 | C609595 |
G2418182 | Certificate of Analysis | Apr 17, 2024 | C609595 |
G2418183 | Certificate of Analysis | Apr 17, 2024 | C609595 |
G2418184 | Certificate of Analysis | Apr 17, 2024 | C609595 |
G2418185 | Certificate of Analysis | Apr 17, 2024 | C609595 |
G2418186 | Certificate of Analysis | Apr 17, 2024 | C609595 |
G2418187 | Certificate of Analysis | Apr 17, 2024 | C609595 |
Solubility | H2O: < 0.1 mg/mL (insoluble) |
---|
1. Ferrari F, Fiorentino S, Mennuni L, Garofalo P, Letari O, Mandelli S, Giordani A, Lanza M, Caselli G. (2011) Analgesic efficacy of CR4056, a novel imidazoline-2 receptor ligand, in rat models of inflammatory and neuropathic pain.. J Pain Res, 4 (3): (111-25). [PMID:21647215] |
2. Thorn DA, Qiu Y, Jia S, Zhang Y, Li JX. (2016) Antinociceptive effects of imidazoline I2 receptor agonists in the formalin test in rats.. Behav Pharmacol, 27 (4): (377-83). [PMID:26599907] |
3. Li JX. (2017) Imidazoline I2 receptors: An update.. Pharmacol Ther, 178 (3): (48-56). [PMID:28322973] |
4. Siemian JN, Wang K, Zhang Y, Li JX. (2018) Mechanisms of imidazoline I2 receptor agonist-induced antinociception in rats: involvement of monoaminergic neurotransmission.. Br J Pharmacol, 175 (9): (1519-1534). [PMID:29451703] |